Posts Tagged ‘corporate lobbyists’

Dr. Elaina   George

Crony Capitalism Can Be Hazardous to Your Health

by Dr. Elaina George

Michael Moore recently pontificated that under Obamacare Americans would have to wait for certain non life-threatening procedures such as a knee replacement. In his mind a “patriotic American” would be happy to do so. If one takes a critical look at socialized healthcare it would be obvious that it doesn’t work. In the UK, the healthcare system is so strapped for money that it is considering outsourcing the management of it to a German company. It is criminal that we would alter our medical system to emulate one that is obviously broken. Despite the pronouncements of healthcare equality we are rapidly moving towards a two tier system that is separate and unequal – those who have the means to do so will simply opt-out.

It is the insertion of Government into the healthcare system that has put us in the position we are in. Cronyism has given corporate interests such as big Pharma, medical insurance companies and hospitals the power to systematically remove competition, control prices and lead to the too big to fail phenomenon that has left doctors and patients on the outside looking in while those who know ‘what is best for us’ continue to gut what was once the best medical system in the world.  The medical insurance industry is an example of a supporter that helped lobby for the passage of Obamacare that has been a big winner.

(more…)

Ken   Boehm

Crony Capitalism: The Love Affair Between the Obama Administration and the World’s Creepiest Company

by Ken Boehm

A major Internet company is under investigation by more than 30 state attorneys-general for alleged wiretapping violations.  In Europe and now Texas that same company faces anti-trust inquiries on whether it unfairly penalizes its competitors, and its operations face criminal wiretapping inquiries throughout Europe, as well as in Australia and South Korea.

google_630x

Yet, inside the Beltway, it’s business as usual.  The Obama Administration plans to award the company a sweetheart, no-bid contract for satellite imagery and access to classified data.  After protests, the Administration backtracks, allowing other companies to bid, but still intends to award the contract to the company.  According to industry sources the total spending in that segment on intelligence outsourcing in 2009 was $161 billion.  This is no small contract.

Surprising? Then how about this: This same company’s executives were among the Obama campaign’s largest contributors. Its CEO stumped for candidate Obama, while he and other senior executives ponied up $150,000 to help pay for the inaugural celebration.

But, it gets even better: The CEO and another senior company official serve as technology advisors to the Administration on issues that directly impact their company.  The company’s senior lobbyist has had multiple secret meetings with senior officials at the National Security Council. Meanwhile, the company’s former top Washington lobbyist now works in the White House overseeing national policy over issues on which he used to lobby.

Is it Halliburton? Exxon? Boeing?  Nope.  The company is Google, the CEO is Eric Schmidt and the joke is on us.

(more…)

Publius

Corporate-Backed ObamaCare

by Publius

From today’s Politico:

At a meeting last April with corporate lobbyists, aides to President Barack Obama and Sen. Max Baucus (D-Mont.) helped set in motion a multimillion-dollar advertising campaign, primarily financed by industry groups, that has played a key role in bolstering public support for health care reform. 

The role Baucus’s chief of staff, Jon Selib, and deputy White House chief of staff Jim Messina played in launching the groups was part of a successful effort by Democrats to enlist traditional enemies of health care reform to their side. No quid pro quo was involved, they insist, as do the lobbyists themselves. 

The result has been a somewhat unlikely alliance between an administration that came into power criticizing George W. Bush for his closeness to Big Business and groups such as the Pharmaceutical Research and Manufacturers of America and the American Medical Association.

Read the whole thing here.